MasTec
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict MasTec's revenues will shrink -3.2% and EPS will increase 19.4%.
The average estimate for revenue is $960.0 million. On the bottom line, the average EPS estimate is $0.43.
Revenue details
Last quarter, MasTec booked revenue of $918.6 million. GAAP reported sales were 24% higher than the prior-year quarter's $738.3 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS details
Last quarter, non-GAAP EPS came in at $0.26. GAAP EPS of $0.22 for Q1 were 29% higher than the prior-year quarter's $0.17 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
Recent performance
For the preceding quarter, gross margin was 13.8%, 210 basis points better than the prior-year quarter. Operating margin was 5.1%, 130 basis points better than the prior-year quarter. Net margin was 2.0%, 10 basis points better than the prior-year quarter.
Looking ahead
The full year's average estimate for revenue is $4.02 billion. The average EPS estimate is $1.80.
Investor sentiment
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 253 members out of 268 rating the stock outperform, and 15 members rating it underperform. Among 77 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 71 give MasTec a green thumbs-up, and six give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on MasTec is outperform, with an average price target of $33.15.
If you're interested in companies like MasTec, you might want to check out the jaw-dropping technology that's about to put 100 million Chinese factory workers out on the street – and the 3 companies that control it. We'll tell you all about them in "The Future is Made in America." Click here for instant access to this free report.
- Add MasTec to My Watchlist.